Cargando…

The role of bone morphogenetic proteins in ankylosing spondylitis

Detalles Bibliográficos
Autor principal:	Lories, Rik J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353584/ http://dx.doi.org/10.1186/ar3723

Ejemplares similares

Imaging of ankylosing spondylitis
por: Østergaard, Mikkel
Publicado: (2012)

Epidemiology of osteoporosis and fractures in ankylosing spondylitis
por: Sambrook, Philip N
Publicado: (2012)

Bone Morphogenetic Protein 6 Polymorphisms Are Associated with Radiographic Progression in Ankylosing Spondylitis
por: Joo, Young Bin, et al.
Publicado: (2014)

Bone morphogenetic proteins in destructive and remodeling arthritis
por: Lories, Rik JU, et al.
Publicado: (2007)

Insight on Bone Morphogenetic Protein 7 in Ankylosing Spondylitis and its association with disease activity and radiographic damage
por: Mahmoud, Adel, et al.
Publicado: (2016)

Enrichment of CD8+ CD28- cytotoxic T cells in circulating lymphocytes of patients with ankylosing spondylitis
por: Schirmer, M, et al.
Publicado: (2001)

Dynamic activation of bone morphogenetic protein signaling in collagen-induced arthritis supports their role in joint homeostasis and disease
por: Daans, Melina, et al.
Publicado: (2008)

A polymorphism within the Transforming Growth Factor β1 gene is associated with ankylosing spondylitis (AS)
por: McGarry, F, et al.
Publicado: (2002)

Expression and regulation of bone morphogenetic protein antagonists in vascular smooth muscle cells
por: Maciel, TT, et al.
Publicado: (2003)

Destructive Dural Ectasia of Dorsal and Lumbar Spine with Cauda Equina Syndrome in a Patient with Ankylosing Spondylitis
por: Van Hoydonck, Marijke, et al.
Publicado: (2010)

In Marseille, Southern France, HLA-B2702 carries higher risk than HLA-B2705 to develop ankylosing spondylitis (AS)
por: Guis, S, et al.
Publicado: (2001)

Positive and negative regulators of transforming growth factor beta 1/bone morphogenetic protein pathways are constitutively expressed in mesangial cells
por: Maciel, TT, et al.
Publicado: (2003)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

Effects of cartilage-derived morphogenetic proteins and osteogenic protein-1 on osteochondrogenic differentiation of periosteum-derived cells
por: Gruber, R, et al.
Publicado: (2001)

Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis
por: De Langhe, Ellen, et al.
Publicado: (2015)

The Role of MicroRNAS in Ankylosing Spondylitis
por: Li, Zheng, et al.
Publicado: (2016)

Alexithymia in ankylosing spondylitis
por: Karabıçak, Deniz, et al.
Publicado: (2021)

Exploring the prevalence and factors associated with fatigue and quality of life in patients with Ankylosing Spondylitis
por: Feki, A., et al.
Publicado: (2023)

The usefulness of trabecular bone score in patients with ankylosing spondylitis
por: Nam, Seoung Wan, et al.
Publicado: (2021)

Role of secukinumab in ankylosing spondylitis with tubercular uveitis
por: Mahendradas, Padmamalini, et al.
Publicado: (2020)

Role of the microbiome and its metabolites in ankylosing spondylitis
por: Song, Zi-Yi, et al.
Publicado: (2022)

Microbes, the gut and ankylosing spondylitis
por: Costello, Mary-Ellen, et al.
Publicado: (2013)

Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed and stimulate proteoglycan synthesis in healthy and osteoarthritic human articular chondrocytes
por: Bobacz, K, et al.
Publicado: (2001)

Bone changes and curative effect of infliximab in patients with ankylosing spondylitis
por: Li, Linying, et al.
Publicado: (2020)

Ankylosing Spondylitis and Cardiac Abnormalities
por: Yang, Dong Heon
Publicado: (2012)

Update on the treatment of ankylosing spondylitis
por: Maksymowych, Walter P
Publicado: (2007)

Ankylosing spondylitis: yesterday and today.
por: Spencer, D G, et al.
Publicado: (1980)

Treat Ankylosing Spondylitis with Methazolamide
por: Chang, Xiaotian, et al.
Publicado: (2011)

Infliximab in the treatment of ankylosing spondylitis
por: Grainger, Rebecca, et al.
Publicado: (2007)

Cardiopulmonary Manifestations of Ankylosing Spondylitis
por: Momeni, Mahnaz, et al.
Publicado: (2011)

Spinal instability in ankylosing spondylitis
por: Badve, Siddharth A, et al.
Publicado: (2010)

Advances in managing ankylosing spondylitis
por: Daikh, David I., et al.
Publicado: (2014)

Trends of Ankylosing Spondylitis Ossification
por: Rozin, Alexander P
Publicado: (2013)

Cardiac Involvement in Ankylosing Spondylitis
por: Ozkan, Yasemin
Publicado: (2016)

Predictors of Atherosclerosis in Ankylosing Spondylitis
por: Verma, Inderjeet, et al.
Publicado: (2015)

Medical Treatment of Ankylosing Spondylitis
por: Moon, Kyoung-Ho, et al.
Publicado: (2014)

Management of ankylosing spondylitis with infliximab
por: Toussirot, Éric, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_dsb6e2gsr5oqjr5j5cu5qfpu6n